Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 20 Other hematologic neoplasm 5 Gynecologic 3 Genitourinary 3 Gastrointestinal 3 Breast 3 Head & Neck 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Plasma cell 1 Myeloid 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 510 Cisplatin 410 Pemetrexed 400 Radiotherapy 285 Docetaxel 244 Paclitaxel 227 pembrolizumab 226 Gemcitabine 198 Drug Therapy 191 Bevacizumab 190 Erlotinib Hydrochloride 189 Radiosurgery 177 Nivolumab 168 Etoposide 155 durvalumab 154 osimertinib 126 atezolizumab 109 Gefitinib 96 Blood Specimen Collection 93 Magnetic Resonance Spectroscopy 91 Vinorelbine 90 anlotinib 88 Surgical Procedures, Operative 85 Ipilimumab 62 Immunotherapy 62 Surveys and Questionnaires 60 sintilimab 59 Specimen Handling 59 tislelizumab 58 Irinotecan 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × copanlisib × Thoracic × Clear all

NCT04895579 2025-11-18

LCD

University of Kentucky

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡